FDA Inspection 801048 — Lydie L. Hazan, M.D.

Lydie L. Hazan, M.D. — FEI 3005993434

The FDA completed an inspection of Lydie L. Hazan, M.D. on September 19, 2012 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance